US Patent Issued to Eli Lilly and Co. on July 14 for "Oxyntomodulin binding molecules, and uses thereof" (Indiana Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,889, issued on July 14, was assigned to Eli Lilly and Co. (Indianapolis).

"Oxyntomodulin binding molecules, and uses thereof" was invented by Robert John Konrad (Carmel, Ind.), Wenyu Ming (Carmel, Ind.), Robert William Siegel II (Fountaintown, Ind.) and Tara Suzanne Umberger (Frankton, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are novel N- and C-terminal oxyntomodulin polypeptide binding molecules, and uses thereof, including a method for quantitating oxyntomodulin."

The patent was filed on Jan. 19, 2022, under Application No. 18/259,892.

*For further information, including images, charts and tables, please visit: http://...